Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Misses Q3 EPS by 21c

November 6, 2018 6:37 AM EST

SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($2.63), $0.21 worse than the analyst estimate of ($2.42).

Guidance:

Based on its current operating plan, Sage anticipates that its existing cash, cash equivalents and marketable securities as of September 30, 2018 will enable Sage to fund its... More